Matches in Nanopublications for { ?s ?p "[This result confirms that the -374AA genotype of the RAGE gene promoter is a protective factor against the severity of CAD lesions in type 2 diabetic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP724408.RAfuavfnynmyERtR5OjW7CkbTJylqitraSE5OPFjkMMJM130_assertion description "[This result confirms that the -374AA genotype of the RAGE gene promoter is a protective factor against the severity of CAD lesions in type 2 diabetic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP724408.RAfuavfnynmyERtR5OjW7CkbTJylqitraSE5OPFjkMMJM130_provenance.
- assertion description "[This result confirms that the -374AA genotype of the RAGE gene promoter is a protective factor against the severity of CAD lesions in type 2 diabetic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP465354.RA6NdmRnleTAN2RDjNFmKrKQ6_FAVCITfZPcM3CQc5qqA130_assertion description "[This result confirms that the -374AA genotype of the RAGE gene promoter is a protective factor against the severity of CAD lesions in type 2 diabetic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP465354.RA6NdmRnleTAN2RDjNFmKrKQ6_FAVCITfZPcM3CQc5qqA130_provenance.
- NP664114.RAfDsObpr-zaHNecop-f6wn0qE2aNUnvhqnj2yrG-hJHU130_assertion description "[This result confirms that the -374AA genotype of the RAGE gene promoter is a protective factor against the severity of CAD lesions in type 2 diabetic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP664114.RAfDsObpr-zaHNecop-f6wn0qE2aNUnvhqnj2yrG-hJHU130_provenance.
- NP634517.RAbfsLj51qh8mgrLvv7NO8kmcscrT7vAyICpn2GVbEzDc130_assertion description "[This result confirms that the -374AA genotype of the RAGE gene promoter is a protective factor against the severity of CAD lesions in type 2 diabetic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634517.RAbfsLj51qh8mgrLvv7NO8kmcscrT7vAyICpn2GVbEzDc130_provenance.
- NP634518.RABTnN2_tXr7mlTYCqmjlD_bjQIJe0vZRMnrR5jMVawYI130_assertion description "[This result confirms that the -374AA genotype of the RAGE gene promoter is a protective factor against the severity of CAD lesions in type 2 diabetic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634518.RABTnN2_tXr7mlTYCqmjlD_bjQIJe0vZRMnrR5jMVawYI130_provenance.
- NP228400.RAusoWtgyHQPxr_HuVeiY-4XrryMsO6ndTO4Tpllx9v3w130_assertion description "[This result confirms that the -374AA genotype of the RAGE gene promoter is a protective factor against the severity of CAD lesions in type 2 diabetic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP228400.RAusoWtgyHQPxr_HuVeiY-4XrryMsO6ndTO4Tpllx9v3w130_provenance.
- NP1017745.RAzsngszURZXs7gEQhghfDNw3EfLdShrqLkg8j7uQCHzA130_assertion description "[This result confirms that the -374AA genotype of the RAGE gene promoter is a protective factor against the severity of CAD lesions in type 2 diabetic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1017745.RAzsngszURZXs7gEQhghfDNw3EfLdShrqLkg8j7uQCHzA130_provenance.
- NP634521.RANScQB0K8e4GXUrn8P6VekEMJtyNVplnmzCRRrbnb9Fs130_assertion description "[This result confirms that the -374AA genotype of the RAGE gene promoter is a protective factor against the severity of CAD lesions in type 2 diabetic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634521.RANScQB0K8e4GXUrn8P6VekEMJtyNVplnmzCRRrbnb9Fs130_provenance.